P&T Committee Review and Decisions |
Name |
Indication |
Decision |
Duavee (conjugated estrogens + bazedoxifene) |
Duavee is used to prevent osteoporosis and treat moderate to severe vasomotor symptoms of menopause in postmenopausal women (with a uterus). |
Continued coverage at • Tier 3 for 3-Tier formulary • Tier 4 for 4-Tier formulary • Tier 3 for Medicare Part D |
Farxiga (dapagliflozin) |
Farxiga and Invokana are used in addition to diet and exercise to improve blood sugar control in adults with type 2 diabetes. |
Continued coverage at • Tier 3 for 3-Tier formulary • Tier 4 for 4-Tier formulary • Tier 4 for Medicare Part D |
Invokana (canagliflozin) |
Continued coverage at • Tier 3 for 3-Tier formulary • Tier 4 for 4-Tier formulary • Tier 4 for Medicare Part D |
|